Category News

Blueprint Medicines Shares 2025 Outlook and Strategic Plans for Sustained Growth

Blueprint Medicines Corporation recently unveiled its 2025 corporate outlook and strategic vision for sustained growth, leveraging its established research, development, and commercial expertise. According to Kate Haviland, Chief Executive Officer of Blueprint Medicines, the company enters 2025 stronger than ever,…

Read MoreBlueprint Medicines Shares 2025 Outlook and Strategic Plans for Sustained Growth

Osimertinib Compared to RYBREVANT® + LAZCLUZE™ Significant and Promising Survival Benefit Observed

Osimertinib: A Benchmark in Targeted Therapy Osimertinib The European Commission has granted approval for the combination of RYBREVANT® (amivantamab) and LAZCLUZE® (lazertinib) for the first-line treatment of adult patients with advanced non-small cell lung cancer (NSCLC) who harbor EGFR exon…

Read MoreOsimertinib Compared to RYBREVANT® + LAZCLUZE™ Significant and Promising Survival Benefit Observed

Promising Formulation of New Sarclisa Subcutaneous Treatment Meets Co-Primary Endpoints in IRAKLIA Phase 3

Formulation Results from the IRAKLIA Phase 3 Study Demonstrate Promise for Subcutaneous Sarclisa in Multiple Myeloma The Formulation IRAKLIA Phase 3 study has presented encouraging results for the investigational subcutaneous (SC) formulation of Sarclisa, administered through an on-body delivery system…

Read MorePromising Formulation of New Sarclisa Subcutaneous Treatment Meets Co-Primary Endpoints in IRAKLIA Phase 3

Biopharma Leaders Head to JPMorgan in Search of a Game-Changing M&A Boost to Revive Market Sentiment 2025

Biopharma Leaders M&A Didn’t Deliver as Expected in 2024: Biopharma Turns to JPMorgan Healthcare Conference for Optimism Biopharma Leaders the much-anticipated mergers and acquisitions (M&A) wave that the biopharma industry hoped would materialize in 2024 did not arrive as expected,…

Read MoreBiopharma Leaders Head to JPMorgan in Search of a Game-Changing M&A Boost to Revive Market Sentiment 2025

Kamal Adwan Hospital Tragically Forced to Close Amid 3 Escalating Raids and Relentless Attacks

The World Health Organization (WHO) has expressed deep dismay following the raid on Kamal Adwan Hospital, which has rendered the last major health facility in North Gaza non-operational. This attack underscores the systematic dismantling of the region’s health infrastructure, coupled…

Read MoreKamal Adwan Hospital Tragically Forced to Close Amid 3 Escalating Raids and Relentless Attacks